Ennov Ready to Support Customers in EMA eCTD 4.0 Customer Pilot Phase 

July 9, 2025

The EMA’s eCTD 4.0 pilot is entering its next stage, and Ennov is ready to support Marketing Authorization Holders (MAHs) who are participating. 

Following our own successful test submission during the technical pilot phase (read more here), we are now prepared to help our customers during the customer pilot phase.  

Ennov’s Regulatory platform is already aligned with EMA’s latest eCTD 4.0 specifications. For customers accepted into the pilot, we can provide the following: 

Please note: Participation in this customer pilot is dependent on selection by EMA. MAH’s must submit their request and provide details of their proposed products, scenarios and very importantly the name of the eCTD v4.0 tool, by 15 July by email to [email protected]. Upon confirmation from EMA will send details on how the test packages can be submitted. 

If your organization has been selected for the pilot and you are preparing to submit, our team is here to help. 

Discover more on eCTD 4 here with these valuable resources. 

  1. eCTD 4.0 key milestones and timeline 
  1. How to prepare for eCTD 4.0 pilots – a handy checklist 
  1. Discover everything on eCTD 4.0 in our Ennovation podcast  

About Ennov

Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 25 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management. Dedicated to innovation and excellence, Ennov’s solutions are used by more than 450 Life Science companies and 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements.

Share :

Facebook
Twitter
LinkedIn

Register for free to access to our library of exclusive content!